Moderna, Inc. (MRNA) financial statements and ratios from SEC XBRL: revenue $1.94B (TTM), net margin -145.2%, revenue growth 2.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.94B |
| Net Margin | -145.2% |
| Revenue Growth (YoY) | 2.1% |
| EPS Growth (YoY) | -7.5% |
| FCF Growth (YoY) | -38.9% |
| Price / Book | 7.69 |
| Price / Sales | 23.33 |
| FCF Yield | -5.9% |
| Altman Z-Score | 8.96 (safe) |
| Piotroski F-Score | 3/9 |
| Sector P/E (Healthcare) | 21.6 |
MRNA overview · MRNA earnings · MRNA KPIs · MRNA investor relations · MRNA ownership · MRNA peers · MRNA filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.